Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: Implications for pandemic preparedness

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Tseng, Yu Fen ^a   Hu, Alan Yung Chih ^a   Huang, Mei Liang ^a   Yeh, Wei Zhou ^a   Weng, Tsai Chuan ^a   Chen, Yu Shuan ^a,b   Chong, Pele ^a   Lee, Min Shi ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

ADAPTATION; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; VACCINE PRODUCTION; VERO CELL; VIRAL GENETICS; VIROGENESIS; VIRUS PURIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; BIOSYNTHESIS; CERCOPITHECUS; CHICKEN; DISASTER PLANNING; DOG; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H5N1; MOLECULAR GENETICS; ORTHOMYXOVIRUS INFECTION; PANDEMIC; VIROLOGY;

AVIAN INFLUENZA VIRUS; MAMMALIA;

ADAPTATION, BIOLOGICAL; ANIMALS; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; CHICKENS; DISASTER PLANNING; DOGS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; VERO CELLS;

EID: 80054748686     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024057     Document Type: Article

References (28)

1. World Health Organization (2007) Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. pp. 164-167.
2. World Health Organization (2006) Global pandemic influenza action plan to increase vaccine supply Geneva.
3. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, et al. (1998) Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16: 960-968.
4. AM P, HS S, V dR, P vE, M B, et al. (1999) Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies. Developments in Biological Standardization 98: 115-125.
5. Audsley JM, Tannock GA, (2004) The role of cell culture vaccines in the control of the next influenza pandemic. Expert Opinion on Biological Therapy 4: 709-717.
6. Doroshenko A, Halperin SA, (2009) Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines). Expert Review of Vaccines 8: 679-688.
7. Nicolson C, Major D, Wood JM, Robertson JS, (2005) Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23: 2943-2952.
8. Horimoto T, Murakami S, Muramoto Y, Yamada S, Fujii K, et al. (2007) Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 366: 23-27.
9. Hu AY-C, Weng T-C, Tseng Y-F, Chen Y-S, Wu C-H, et al. (2008) Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 26: 5736-5740.
10. MK H, O K, PN B, (2008) Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines. Biological Chemistry 389: 569-577.
11. Barrett PN, Mundt W, Kistner O, Howard MK, (2009) Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Review of Vaccines 8: 607-618.
12. ED K, (1969) Future influenza vaccines and the use of genetic recombinants. Bulletin World Health Organ 41: 643-645.
13. HF M Jr, FT, FM D, AV H, E M, et al. (1969) Laboratory and clinical characteristics of attenuated strains of influenza virus. Bulletin World Health Organ 41: 589-594.
14. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
15. Govorkova EA, Kaverin NV, Gubareva LV, Meignier B, Webster RG, (1995) Replication of Influenza A Viruses in a Green Monkey Kidney Continuous Cell Line (Vero). Journal of Infectious Diseases 172: 250-253.
16. Kaverin N, Webster R, (1995) Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol 69: 2700-2703.
17. Govorkova E, Murti G, Meignier B, de Taisne C, Webster R, (1996) African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol 70: 5519-5524.
18. Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, et al. (2009) Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine 27: 2907-2913.
19. Ozaki H, Govorkova EA, Li C, Xiong X, Webster RG, et al. (2004) Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse Genetics. J Virol 78: 1851-1857.
20. Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, et al. (2004) Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. The Lancet 363: 1099-1103.
21. Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, et al. (2006) Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets. PLoS Med 3: e360.
22. Stephenson I, (2006) H5N1 vaccines: how prepared are we for a pandemic? The Lancet 368: 965-966.
23. Ehrlich HJ, Müller M, Oh HML, Tambyah PA, Joukhadar C, et al. (2008) A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture. New England Journal of Medicine 358: 2573-2584.
24. Murakami S, Horimoto T, Mai LQ, Nidom CA, Chen H, et al. (2008) Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells. J Virol 82: 10502-10509.
25. Palache B, Krause R, (2009) Progress with human H5N1 vaccines: a perspective from industry. Expert Review of Vaccines 8: 391-400.
26. Collin N, de Radiguès X, (2009) Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27: 5184-5186.
27. Partridge J, Kieny MP, (2010) Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 28: 4709-4712.
28. World Health Organization (2002) WHO manual on animal influenza diagnosis and surveillance Geneva World Health Organization.